Peptide profiles and research notes.

ACE-031 (ActRIIB-Fc) is a recombinant soluble ActRIIB fusion protein that acts as a decoy receptor for myostatin and related activins. Early studies showed increases in lean mass, but functional strength benefits were inconsistent and the program was halted after vascular safety concerns.

AOD-9604 is a modified fragment of human growth hormone (hGH) derived from residues 176-191. In preclinical studies, it was associated with fat-metabolism effects such as increased lipolysis and reduced lipogenesis, without the growth-promoting or diabetogenic effects of full-length hGH. Original research focused on obesity and body-composition management. Later larger studies did not establish it as an approved therapy, so current evidence should be treated as investigational.

Apelin-13 is a naturally occurring peptide that binds to the APJ receptor and is studied for its role in cardiovascular function and metabolism. Most claims about benefit are preclinical or investigational, so any therapeutic or combination-use framing should be interpreted cautiously.

Ara 290 is a synthetic peptide that mimics the structure of erythropoietin, specifically targeting the innate repair receptor (IRR). This unique mechanism allows it to promote tissue healing and nerve regeneration without the side effects associated with traditional erythropoietin therapy. It has shown particular promise in treating diabetic neuropathy, reducing inflammation, and supporting wound healing. The peptide works by activating tissue repair pathways and modulating the immune response, making it a valuable tool in both acute and chronic healing scenarios. Research suggests it may also help protect against oxidative stress and improve cellular function.

Argireline (Acetyl hexapeptide-3 or Ac-EEMQRR-NH2) is a synthetic, biomimetic peptide that functions as a topical anti-wrinkle agent primarily through a neuromodulatory mechanism. Its key characteristic is its structural mimicry of the N-terminal domain of SNAP-25, a protein essential for the assembly of the SNARE complex that mediates vesicle fusion and neurotransmitter release at neuromuscular junctions. By competitively inhibiting this complex formation, Argireline reduces the release of neurotransmitters, especially acetylcholine, from synaptic vesicles, leading to a localized, reversible relaxation of facial muscle contractions. This mechanism is often described as a 'topical botox-like effect,' though it is less potent and invasive. Primary research focuses on its application in cosmetic dermatology for diminishing the appearance of dynamic expression lines, particularly on the forehead and around the eyes. Key characteristics include its hexapeptide sequence, acetylated N-terminus and amidated C-terminus for stability, good skin penetration due to its small size and lipophilicity, and a safety profile that favors topical use over injectable neurotoxins. Research also explores its potential synergistic effects with other peptides and antioxidants in skincare formulations.

BPC-157 (Body Protection Compound-157) is a synthetic peptide derived from a gastric juice protein and studied primarily in preclinical models. Most of the reported activity comes from animal and laboratory research, where it has been associated with tissue repair, angiogenesis, nitric oxide modulation, anti-inflammatory effects, and gastrointestinal protection. Human evidence remains limited, so it should be treated as an investigational compound rather than a proven therapy.

Cagrilintide is a long-acting synthetic amylin analogue under investigation for obesity and overweight management. It acts through amylin and calcitonin receptor pathways to reduce appetite, increase satiety, and support weight loss.

Cerebrolysin is a neurotrophic peptide preparation derived from porcine brain tissue that contains a complex mixture of biologically active peptides. It has been used clinically for decades in some countries for cerebrovascular and neurorehabilitation indications. It is thought to act through multiple mechanisms, including promoting neurogenesis, enhancing synaptic plasticity, improving neuronal survival, and protecting against oxidative stress. It has been studied for stroke, traumatic brain injury, and neurodegenerative conditions like Alzheimer's disease, but the evidence base is mixed across indications. Research has reported potential improvements in memory, learning, attention, and overall cognitive performance while providing neuroprotective benefits. The peptide is often discussed for its potential role in brain injury recovery and cognitive support in aging populations.

CJC-1295 is a synthetic growth hormone releasing hormone (GHRH) analog designed to increase growth hormone secretion and IGF-1 levels. It comes in two variants: with and without Drug Affinity Complex (DAC). The DAC version has a significantly longer half-life (about 8 days versus minutes for the non-DAC version) due to its ability to bind to albumin in the bloodstream. CJC-1295 works by binding to GHRH receptors on the pituitary gland, stimulating the production and release of endogenous growth hormone. This leads to more natural GH pulses compared to exogenous GH administration. Benefits include increased muscle mass, reduced body fat, improved recovery, enhanced sleep quality, and potential anti-aging effects. It is often combined with GHRPs like Ipamorelin for complementary GH-release effects.

Preclinical and limited exploratory research suggests Cortagen may help support stress-response regulation through effects on CRH and ACTH signaling. The peptide has been studied for possible effects on stress-related symptoms, sleep quality, and cognition under stress. Any use beyond research should be treated cautiously because robust human evidence is not established.

Desmopressin is a synthetic analog of vasopressin that has been modified to have a longer duration of action and more specific effects. It works by binding to vasopressin receptors in the kidneys, promoting water retention and reducing urine production. The peptide has shown effectiveness in treating conditions like diabetes insipidus, nocturnal enuresis (bedwetting), and certain bleeding disorders. Desmopressin is particularly valuable for its ability to reduce nighttime urination and support proper fluid balance. Research suggests it may help improve sleep quality by reducing nighttime bathroom visits and supporting proper blood clotting in certain conditions. The peptide is often used in combination with other treatments for comprehensive management of fluid balance disorders.

Dihexa is a synthetic peptide derived from angiotensin IV that was developed at Washington State University as a potential treatment for neurodegenerative conditions like Alzheimer's disease. It has been dubbed a "neurogenic nootropic" for its remarkable ability to stimulate neuronal growth and connectivity. Dihexa works by enhancing the activity of hepatocyte growth factor (HGF) and its receptor c-Met, a system critical for neurogenesis and synaptogenesis. Research suggests it's approximately 7 million times more potent than BDNF (brain-derived neurotrophic factor) at promoting neuronal growth and connectivity. In animal studies, Dihexa has demonstrated the ability to reverse cognitive impairment caused by various forms of brain damage and neurotoxicity. It has shown potential for treating conditions characterized by neuronal loss or dysfunction, including Alzheimer's disease, Parkinson's disease, and stroke-related damage. Unlike many nootropics that primarily modulate neurotransmitters, Dihexa focuses on structural changes in the brain, potentially offering more fundamental and lasting cognitive benefits.

Delta Sleep-Inducing Peptide (DSIP) is a neuropeptide originally isolated from rabbit brain during sleep research. It has been studied for possible effects on sleep quality, stress response, and pain modulation, but the human evidence remains limited and mixed. Its precise receptor and full mechanism are still incompletely characterized. Claims about anti-aging or broad therapeutic benefit should be treated as investigational rather than established.

Epithalon is a synthetic peptide that mimics the naturally occurring epithalamin peptide, playing a role in regulating biological rhythms and supporting longevity. It has been studied for its effects on pineal melatonin production and telomere biology, with preclinical and limited human data suggesting possible benefits for immune function, cellular health, and age-related decline. The peptide is particularly valued in research settings for its potential role in circadian rhythm regulation and broader longevity pathways.

FGL is a synthetic NCAM-derived 15-amino-acid peptide that corresponds to the FG loop binding site used by NCAM to engage FGFR1. In research models it has been studied as a neurotrophic and neuroprotective agent with effects on synaptic plasticity, neurite outgrowth, and memory-related processes. Preclinical work suggests potential relevance for cognitive decline and brain injury, while human evidence remains limited and investigational.

Follistatin 344 is an endogenous follistatin isoform studied for its ability to bind activins and myostatin-family ligands. By reducing signaling through those pathways, it may influence muscle growth in experimental models. Human evidence remains limited, and most data come from preclinical research or regulated gene-therapy studies rather than routine clinical use.

FOXO4-DRI is a D-retro-inverso senolytic peptide that disrupts the FOXO4-p53 interaction in senescent cells. In preclinical models, this releases p53-mediated apoptotic signaling and is used to study senescence clearance, chemotoxicity, and aging-related tissue dysfunction.

GHK-Cu (Glycine-Histidine-Lysine Copper Peptide) is a naturally occurring tripeptide complexed with copper that plays significant roles in skin health and regeneration. First discovered in human plasma, its levels decline with age, from roughly 200 ng/mL around age 20 to about 80 ng/mL by age 60. This peptide stimulates collagen production, enhances elastin synthesis, and improves skin firmness and elasticity. It also exhibits antioxidant properties, helping protect skin cells from UV damage and environmental toxins. GHK-Cu accelerates wound healing by attracting immune cells to the injury site and stimulating the growth of new blood vessels. Additionally, it promotes hair growth by stimulating follicle cells and has shown potential for reducing inflammation and pain in various conditions.

Ghrelin is a naturally occurring peptide hormone that plays a crucial role in appetite regulation and growth hormone release. It works by binding to the growth hormone secretagogue receptor (GHS-R1a), stimulating appetite and growth hormone production. The peptide has been studied for appetite regulation, growth hormone release, and metabolic effects. Research suggests it may influence metabolic regulation and support overall health. Ghrelin is particularly notable for linking appetite control with hormonal signaling. The peptide is often discussed alongside other compounds that affect metabolism.

GHRP-1 (Growth Hormone Releasing Peptide-1) is a synthetic heptapeptide that stimulates growth hormone release from the pituitary gland. It works by binding to the ghrelin receptor (GHS-R1a), triggering a cascade of events that leads to GH release. The peptide has shown effectiveness in increasing growth hormone levels, promoting muscle growth, and enhancing recovery. Research suggests it may help improve sleep quality and support healthy metabolism. GHRP-1 is known for its moderate appetite-stimulating effects, making it a good choice for those who want to avoid the strong hunger effects of other GHRPs. The peptide is often used in combination with CJC-1295 or other growth hormone peptides for enhanced effects on muscle development and recovery.

GHRP-2 (Growth Hormone Releasing Peptide-2) is a synthetic hexapeptide and a second-generation growth hormone secretagogue. It's more potent than GHRP-6, producing stronger GH release while causing less hunger stimulation. Like other GHRPs, it works by mimicking ghrelin and binding to the GHS-R1a receptor in the pituitary and hypothalamus, but with greater efficacy and selectivity. GHRP-2 triggers a significant pulse of growth hormone release, leading to increased muscle mass, enhanced fat loss, improved recovery, and better sleep quality. Compared to GHRP-6, it offers more potent GH stimulation with fewer side effects, though it still may cause some increases in cortisol and prolactin. It has a relatively short half-life of about 20 minutes, requiring multiple daily administrations for optimal results. GHRP-2 is typically combined with GHRH analogs like CJC-1295 for synergistic effects on GH release patterns and amplitudes.

GHRP-6 (Growth Hormone Releasing Peptide-6) is a synthetic hexapeptide and ghrelin receptor agonist that stimulates growth hormone release and appetite. It has been studied in research settings for increasing GH secretion and supporting body-composition goals through higher caloric intake. It is often discussed alongside CJC-1295 or other growth hormone secretagogues in protocols aimed at amplifying pulsatile GH signaling, although direct anabolic effects are not well established.

GHRP-Kp is a synthetic peptide that combines the effects of GHRP and Kisspeptin, playing a crucial role in growth hormone release and performance enhancement. It works by binding to both GHS-R1a and Kisspeptin receptors, triggering a significant release of growth hormone. The peptide has shown effectiveness in increasing growth hormone levels, enhancing recovery, and improving performance. Research suggests it may help prevent performance decline and support overall health. GHRP-Kp is particularly valuable for its ability to stimulate growth hormone release while supporting performance enhancement. The peptide is often used in combination with exercise and proper nutrition for optimal results.

GLP-1 (Glucagon-Like Peptide-1) is an endogenous incretin hormone produced in the intestines after food consumption. Synthetic incretin-based therapies such as semaglutide and liraglutide, and dual GIP/GLP-1 agonists such as tirzepatide, extend these effects with longer half-lives. These medications bind to GLP-1 receptors throughout the body, particularly in the pancreas and brain, producing multiple metabolic effects. They stimulate insulin release from pancreatic beta cells in a glucose-dependent manner, improving blood sugar control with a low intrinsic risk of hypoglycemia. In the brain, they activate satiety centers and slow gastric emptying, reducing hunger and food intake. GLP-1 agonists may also support pancreatic beta-cell function over time, although that effect remains under study in humans. Originally developed for type 2 diabetes treatment, these medications have shown remarkable effectiveness for weight management, with newer agents like semaglutide and tirzepatide producing average weight losses of 15-20% in clinical trials. Recent research suggests potential benefits for cardiovascular health and metabolic liver disease, with ongoing investigation into possible neuroprotective effects.

Glutathione is a tripeptide composed of glutamate, cysteine, and glycine. In its reduced form (GSH), it has the chemical formula C10H17N3O6S. It is a potent antioxidant that helps protect cells from oxidative stress and supports cellular redox balance. Its mechanism involves neutralizing reactive oxygen species (ROS) and free radicals while helping regenerate other antioxidants such as vitamins C and E. Glutathione is also central to detoxification in the liver, where it conjugates with toxins and supports excretion. It is commonly discussed for immune support, oxidative damage control, and detoxification, and it also participates in DNA synthesis and repair, protein synthesis, and immune modulation. Glutathione exists in reduced (GSH) and oxidized (GSSG) forms, is present in nearly all cells, and can decline with age or chronic illness, which is why precursor support such as N-acetylcysteine (NAC) is commonly discussed in clinical and wellness settings.

Gonadorelin is a synthetic analog of gonadotropin-releasing hormone (GnRH) that stimulates the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). It works by binding to GnRH receptors in the pituitary gland, triggering the release of reproductive hormones. In fertility and hypogonadotropic hypogonadism settings, it has been used to support endogenous testosterone production and reproductive function. Research on age-related hormonal decline remains limited.

Hexarelin is a synthetic hexapeptide that acts as a potent growth hormone secretagogue by binding to the ghrelin receptor (GHS-R1a) and stimulating growth hormone release. Human studies mainly support its acute endocrine effects and appetite stimulation; evidence for durable muscle-growth or body-composition benefits remains limited.

HGH Fragment 176-191 is a synthetic C-terminal fragment of human growth hormone spanning residues 176-191. Preclinical studies have reported effects on lipid metabolism, including reduced lipogenesis and increased adipose-tissue lipolysis, but the exact mechanism and clinical relevance remain uncertain.

HGH Somatropin (Human Growth Hormone Somatropin) is a synthetic peptide hormone identical to the endogenous growth hormone produced by the anterior pituitary gland. Its primary mechanism of action involves binding to growth hormone receptors in target tissues, stimulating the production of insulin-like growth factor 1 (IGF-1) in the liver and other tissues. This promotes cellular growth, proliferation, and regeneration, as well as metabolic processes such as protein synthesis, lipolysis, and carbohydrate metabolism. Primary uses of HGH Somatropin include the treatment of growth hormone deficiency (GHD) in children and adults, Turner syndrome, chronic kidney disease-related growth failure in children, and muscle-wasting conditions associated with HIV/AIDS. It is also used off-label for anti-aging, athletic performance enhancement, and recovery from injuries. Key characteristics of HGH Somatropin include its 191-amino acid sequence, molecular weight of approximately 22 kDa, and its short half-life of about 2–4 hours when administered subcutaneously. It is typically administered via injection and requires careful dosing to avoid side effects such as joint pain, insulin resistance, and edema. The peptide is highly sensitive to temperature and must be stored refrigerated to maintain stability.

Humanin is a 24-amino acid mitochondrial-derived peptide originally discovered in surviving neurons of Alzheimer's disease patients. It is encoded within the mitochondrial 16S rRNA gene and represents one of the first identified mitochondrial-derived peptides (MDPs). Humanin primarily functions as a neuroprotective agent with cytoprotective effects against oxidative stress, ischemia, and amyloid-beta toxicity. It works through multiple mechanisms, including activating cell survival pathways (STAT3, ERK1/2), inhibiting apoptotic pathways, and improving mitochondrial function. Beyond neuroprotection, Humanin has been studied for effects on glucose metabolism, insulin sensitivity, inflammation, and cardiovascular protection. Age-related declines in Humanin levels may contribute to neurodegenerative and metabolic dysfunction, making it a promising therapeutic research target.

Ibutamoren (MK-677) is a potent, orally active growth hormone secretagogue that stimulates the release of growth hormone and IGF-1 through activation of the ghrelin receptor. Unlike traditional growth hormone therapy, it works by mimicking the natural hormone ghrelin, which stimulates the pituitary gland to release growth hormone. This oral growth hormone secretagogue has shown potential for increasing muscle mass, improving bone density, and enhancing exercise recovery. It has also been studied for effects on sleep quality and sustained growth hormone elevation.

IGF-1 LR3 (Long R3 Insulin-like Growth Factor-1) is a modified version of IGF-1 with enhanced potency and longer half-life. It's a key mediator of growth hormone's effects on muscle growth and tissue repair. The peptide works by binding to IGF-1 receptors throughout the body, promoting protein synthesis, cell growth, and tissue regeneration. IGF-1 LR3 has shown remarkable effectiveness in promoting muscle hypertrophy, enhancing recovery from exercise and injuries, and supporting overall tissue health. The peptide is particularly valuable for its ability to stimulate muscle growth while also supporting joint health and recovery. Research suggests it may help prevent muscle loss during aging and support recovery from various types of tissue damage. IGF-1 LR3 is often used in combination with growth hormone peptides for synergistic effects on muscle growth and recovery.

Ipamorelin is a selective growth hormone secretagogue and ghrelin mimetic that stimulates the pituitary gland to release growth hormone. Compared with less selective growth hormone secretagogues, it has been reported to have minimal impact on cortisol and prolactin in published studies, which is why it is often described as having a more favorable side-effect profile. It works by binding to the ghrelin receptor (GHSR), triggering a cascade that leads to GH release. Potential benefits discussed in the literature include changes in body composition and recovery, although much of the evidence is limited or early-stage. Ipamorelin is often discussed alongside CJC-1295 for combined GH-axis research.

Kisspeptin is a naturally occurring peptide that plays a crucial role in regulating reproductive hormones and sexual function. It works by stimulating the release of gonadotropin-releasing hormone (GnRH) from the hypothalamus, which in turn triggers the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the pituitary gland. This cascade of hormone release is essential for maintaining healthy reproductive function, libido, and fertility. Kisspeptin has been studied in clinical research for reproductive disorders, including hypogonadism, infertility, and sexual dysfunction. Research suggests it may help restore natural hormone production in individuals with disrupted hypothalamic-pituitary-gonadal axis function. The peptide is particularly relevant for its potential to support fertility and sexual function while informing overall hormonal health research.

KPV (Lysine-Proline-Valine) is a tripeptide and the C-terminal fragment of α-MSH (alpha-melanocyte-stimulating hormone). Research suggests it retains anti-inflammatory activity while lacking the pigmentary effects of the full hormone. Studies indicate KPV can inhibit NF-κB signaling, reduce pro-inflammatory cytokines, and support inflammatory control in preclinical skin and gut models. Its small size may help formulation-dependent topical delivery. Evidence is strongest in laboratory and animal studies, with limited direct human data.

Kyotorphin is a naturally occurring peptide that plays a crucial role in pain management and neuroprotection. It works by modulating pain perception and supporting neuronal health. The peptide has shown effectiveness in reducing pain, protecting neurons, and supporting recovery. Research suggests it may help prevent neurological dysfunction and support overall health. Kyotorphin is particularly valuable for its ability to manage pain while supporting neurological health. The peptide is often used in combination with other neuroprotective compounds for comprehensive benefits.

Leuprorelin is a synthetic nonapeptide analog of gonadotropin-releasing hormone (GnRH). Its primary mechanism of action involves initial stimulation followed by profound and sustained desensitization of pituitary GnRH receptors, leading to a downregulation of gonadotropin (LH and FSH) secretion and, consequently, a suppression of gonadal steroidogenesis. This results in a medical castration state. In research, it is extensively used as a model compound to study the effects of sex hormone ablation in various contexts, including oncology (e.g., prostate and breast cancer models), endocrinology (e.g., precocious puberty, endometriosis), and reproductive biology. Key characteristics include its high potency, superagonist activity, and the necessity for sustained-release depot formulations (e.g., acetate or pamoate salts) to maintain continuous receptor downregulation, which distinguishes it from native GnRH's pulsatile action. Its peptide structure (pGlu-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt) incorporates a D-amino acid substitution to enhance metabolic stability.

Lipo-C is a specialized lipotropic formulation that combines Methionine, Inositol, and Choline to create a synergistic blend with multifaceted benefits. Its mechanism of action is rooted in the unique properties of its components: Methionine acts as an essential sulfur-containing amino acid that supports liver detoxification and antioxidant activity; Inositol functions as a pseudovitamin that aids in cellular signaling, insulin sensitivity, and lipid metabolism; and Choline serves as a precursor for acetylcholine and phospholipids, crucial for brain function and liver health. Together, these compounds enhance lipid metabolism, promote detoxification, and support cognitive and hepatic functions. Primary uses of Lipo-C include liver support, fat metabolism optimization, cognitive enhancement, and detoxification protocols. Key characteristics of this formulation include its ability to improve methylation processes, reduce fatty liver deposits, and bolster neurotransmitter production, making it a versatile supplement for metabolic and neurological health.

LL-37 is a naturally occurring antimicrobial peptide (AMP) that forms part of the human innate immune system. This 37-amino acid peptide is derived from the C-terminal of the human cathelicidin protein hCAP18 and is produced by various cells, including neutrophils, macrophages, and epithelial cells of the skin, respiratory tract, and gastrointestinal system. LL-37 has powerful antimicrobial properties against bacteria, viruses, and fungi by disrupting their membrane integrity. Beyond direct antimicrobial actions, LL-37 modulates immune responses, promotes wound healing by enhancing cell migration and angiogenesis, and has anti-inflammatory properties. These multiple mechanisms make LL-37 valuable for treating chronic infections, particularly biofilm-associated infections, wound healing, and addressing certain inflammatory conditions.

Macimorelin is a synthetic ghrelin receptor agonist used to diagnose adult growth hormone deficiency. It binds to GHS-R1a and stimulates growth hormone release from the anterior pituitary after a single oral dose. Serum GH is then measured at 30, 45, 60, and 90 minutes to assess the response. The labeled test uses 0.5 mg/kg after at least 8 hours of fasting. Use is not established for BMI > 40 kg/m2, and the label advises avoiding QT-prolonging drugs, strong CYP3A4 inducers, and medications that affect growth hormone release before testing.

Matrixyl is Sederma's trademarked anti-wrinkle active based on palmitoyl pentapeptide-4. It is used in leave-on cosmetic formulas to support fibroblast signaling and the synthesis of collagen and glycosaminoglycans, helping soften the look of wrinkles and support skin firmness.

Melanotan I (also known as Afamelanotide) is a synthetic linear tridecapeptide analog of α-melanocyte-stimulating hormone (α-MSH). Its primary mechanism of action is agonist activity at the melanocortin 1 receptor (MC1R), which stimulates melanogenesis and increases eumelanin production in skin melanocytes, leading to skin pigmentation without direct UV exposure. Key characteristics include its stability against enzymatic degradation compared to α-MSH and its ability to induce tanning. Primary research uses have focused on photoprotection for individuals with erythropoietic protoporphyria (EPP) and other photosensitivity disorders, with clinical applications exploring its potential in reducing phototoxicity. Research also investigates its role in modulating inflammation and oxidative stress.

Melanotan II is a synthetic cyclic heptapeptide analog of α-melanocyte-stimulating hormone (α-MSH). Its primary mechanism of action is non-selective agonism of melanocortin receptors (MCRs), with high affinity for MC1R, MC3R, MC4R, and MC5R. Activation of MC1R on melanocytes stimulates eumelanin production, leading to skin pigmentation without UV exposure. Its action on MC4R in the central nervous system is associated with appetite suppression, increased libido, and potential erectile function modulation. In research contexts, it has been primarily investigated for its potential in photoprotection against UV-induced damage, as a probe for studying melanocortin receptor signaling pathways, and for exploring treatments for sexual dysfunction and obesity. Key characteristics include its cyclic structure (Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2), which enhances metabolic stability compared to linear peptides, and its ability to induce rapid and prolonged tanning. It is a research chemical with no approved medical use.

MGF (Mechano Growth Factor) is an IGF-1 splice variant produced in response to mechanical stress (exercise). It has been studied as a local signaling factor in muscle growth and repair, including satellite cell activation and tissue regeneration. Its exact receptor biology and in-vivo effects remain less certain than the broader IGF-1 literature suggests, so the most defensible framing is that it is an experimental candidate for localized recovery support rather than a proven therapeutic. Research suggests it may help support recovery from muscle injury and may be relevant to muscle preservation during aging. It is often discussed alongside other growth factors like IGF-1 LR3, although those combinations remain experimental.

MOTS-c is a novel mitochondrial-derived peptide of 16 amino acids encoded within mitochondrial DNA. Unlike most peptides that target surface receptors, MOTS-c works primarily through metabolic pathways. It functions as a metabolic regulator that improves insulin sensitivity and glucose metabolism. It activates AMPK (AMP-activated protein kinase), a key enzyme that regulates cellular energy homeostasis, prompting cells to shift from fat synthesis to fat oxidation. This metabolic reprogramming helps improve exercise capacity, enhance glucose uptake, promote fat burning, and potentially counteract age-related insulin resistance. Research suggests MOTS-c may function as an exercise mimetic, producing some metabolic benefits of exercise even without physical activity. Its mitochondrial origin and metabolic effects make it a promising research candidate for metabolic disorders and age-related conditions.

NAD+ (Nicotinamide Adenine Dinucleotide) is a fundamental coenzyme present in all living cells, playing a crucial role in cellular energy production, DNA repair, and metabolic function. As we age, NAD+ levels naturally decline, which has been linked to age-related changes in cellular resilience and metabolism. This molecule is involved in multiple cellular processes, including the conversion of food into energy, regulation of circadian rhythms, and maintenance of DNA integrity. NAD+ supplementation strategies and precursor research have been studied for their potential to support mitochondrial function, cellular repair, and healthy aging. It works by supporting mitochondrial function, activating sirtuins (longevity proteins), and promoting cellular repair mechanisms. Research suggests that maintaining optimal NAD+ levels may help protect against age-related decline and improve overall cellular health.

Oxytocin is a naturally occurring peptide hormone involved in social bonding, mood regulation, and stress responses. It binds to oxytocin receptors throughout the body, especially in the brain, where it modulates social behavior, emotional responses, and stress reactivity. Oxytocin has been studied for potential effects on social connection, anxiety, and mood, but human findings are mixed and its therapeutic role remains investigational. It has also been explored in research on social anxiety, depression, and post-traumatic stress disorder, often alongside psychotherapy in controlled settings.

PEG-MGF is a polyethylene glycol-modified version of MGF that has an extended half-life and may produce more prolonged systemic exposure. This modification is intended to keep the peptide active longer and may affect multiple muscle groups over time. PEG-MGF is generally discussed as an MGF-related peptide rather than a well-characterized, approved therapy. Preclinical and anecdotal reports suggest possible roles in muscle growth, recovery, and tissue repair, especially during injury rehabilitation or periods of reduced activity. It is often described in combination with other growth factors in research-oriented discussions.

Pinealon is a synthetic tripeptide (Glu-Asp-Arg) studied in Russian bioregulatory literature as a brain-directed peptide. Available reports describe possible benefits for memory, attention, stress resilience, and sleep quality in age-related or post-injury CNS impairment, but the human evidence base is limited and regional. It should be treated as an investigational compound rather than an established therapy.

Pralmorelin is a synthetic growth hormone secretagogue used primarily for diagnostic purposes to evaluate growth hormone deficiency. It works by binding to ghrelin receptors in the pituitary gland, stimulating the release of growth hormone. The peptide has shown effectiveness in accurately assessing growth hormone production and pituitary function. Pralmorelin is particularly valuable for its ability to provide reliable diagnostic information about growth hormone status. Research suggests it may help identify various pituitary disorders and guide appropriate treatment decisions. The peptide is often used in combination with other diagnostic tests for comprehensive evaluation of growth hormone function.

PT-141 (Bremelanotide) is a synthetic cyclic heptapeptide analog of α-melanocyte-stimulating hormone (α-MSH). Its primary mechanism of action is as a potent agonist of melanocortin receptors, with selectivity for the MC4R and MC3R subtypes in the central nervous system. Activation of these receptors, particularly in hypothalamic pathways, modulates dopaminergic signaling and influences sexual arousal and desire independent of the gonadal steroid hormone pathway. Its key characteristics include subcutaneous administration, non-hormonal action, and central nervous system activity. Primary research uses have focused on treating hypoactive sexual desire disorder (HSDD), with investigation into its pro-sexual effects and potential utility in addressing sexual dysfunction associated with antidepressants. It is distinct from phosphodiesterase type 5 inhibitors as it acts centrally on desire rather than peripherally on erectile function.

Retatrutide represents the next generation of weight loss therapies as the first triple agonist targeting GLP-1, GIP, and glucagon receptors. This innovative approach combines the appetite-suppressing effects of GLP-1 and GIP with the metabolic benefits of glucagon receptor activation. Early clinical trials have shown unprecedented weight loss results, with average reductions of 20-25% of body weight at the highest dose. Retatrutide works through a comprehensive mechanism: GLP-1 reduces appetite and slows gastric emptying, GIP improves insulin sensitivity and enhances the effects of GLP-1, while glucagon increases energy expenditure and fat burning. This triple action not only promotes significant weight loss but also improves metabolic health, insulin sensitivity, and cardiovascular risk factors. Retatrutide has shown particular promise in individuals with severe obesity and those who have not achieved sufficient results with other weight loss therapies.

Selank is a synthetic peptide developed in Russia, derived from the endogenous tetrapeptide tuftsin with an added Pro-Gly-Pro stabilizing sequence. Originally developed as an immune modulator, Selank has gained recognition for its anxiolytic (anti-anxiety) and nootropic (cognitive-enhancing) properties without causing sedation or addiction. It works by modulating brain-derived neurotrophic factor (BDNF) and serotonin levels while inhibiting enkephalin-degrading enzymes, which prolongs the effects of enkephalins and related endogenous opioid peptides in the brain. This mechanism provides anxiety relief without the sedation, dependence, or cognitive impairment associated with benzodiazepines. Selank has been shown to improve learning and memory formation, enhance focus and attention, reduce anxiety and stress, and potentially boost immune function. Its balanced effects on cognition and mood, combined with an excellent safety profile and lack of addiction potential, make it a valuable tool for treating anxiety disorders while preserving or enhancing cognitive function.

Semaglutide (Wegovy/Ozempic) has revolutionized weight loss treatment as a highly effective GLP-1 receptor agonist. Its long half-life of approximately one week allows for once-weekly dosing, making it more convenient than earlier GLP-1 medications. Clinical trials have shown average weight loss of 12-15% of body weight at the 2.4mg dose, with significant improvements in quality of life and obesity-related comorbidities. The medication works through multiple pathways: reducing hunger and food cravings, increasing feelings of fullness, slowing gastric emptying, and improving insulin sensitivity. Beyond weight loss, it has demonstrated significant benefits in reducing cardiovascular risk, improving blood pressure, and enhancing metabolic health. The medication has been particularly effective in individuals with obesity-related conditions such as type 2 diabetes, where it provides dual benefits of weight loss and improved glycemic control.

Semax is a synthetic peptide developed in Russia, derived from a fragment of ACTH (adrenocorticotropic hormone) with an added stabilizing sequence. It's primarily known for its nootropic (cognitive-enhancing) and neuroprotective properties. Semax works through multiple mechanisms, including enhancing brain-derived neurotrophic factor (BDNF) expression, which promotes neuronal growth and protection; improving selective attention by modulating neurotransmitters, particularly dopamine; and providing neuroprotection against oxidative stress and cerebral ischemia. It's been shown to enhance learning and memory, increase attention and focus, accelerate processing speed, and protect neurons from damage. Unlike many cognitive enhancers, Semax doesn't cause overstimulation or addiction, and it doesn't significantly affect heart rate or blood pressure. In Russia, it's an approved medication for stroke treatment, cognitive enhancement, and immune modulation. Semax is frequently compared to Noopept but offers a broader range of effects and potentially greater neuroprotection with fewer side effects.

Semaxin is a dietary supplement marketed to support male fertility and sexual performance. The product page describes a 12-ingredient formula built around NAC, astragalus, vitamins, minerals, tribulus, saffron, and maca. Its claims focus on semen quality, libido, erections, and testosterone support rather than peptide pharmacology.

Sermorelin is a synthetic analog of growth hormone-releasing hormone (GHRH) that stimulates the natural production of growth hormone. It works by binding to GHRH receptors in the pituitary gland, triggering the release of endogenous growth hormone. The peptide has shown effectiveness in increasing growth hormone levels, supporting muscle growth, and enhancing recovery. Research suggests it may help prevent age-related decline in growth hormone production and support healthy aging. Sermorelin was historically marketed in the U.S. as Geref Diagnostic, but that product was later withdrawn. The peptide is often used in combination with other growth hormone peptides for enhanced effects.

Snap 8 is an advanced anti-aging peptide that works through a mechanism similar to Botox, but without the need for injections. This octapeptide is designed to mimic part of SNAP-25 and interfere with SNARE complex formation, which may help reduce the appearance of expression lines and wrinkles. It is often used in topical formulations and is marketed for gradual, natural-looking results. It is often combined with other anti-aging peptides for enhanced results, and its gentle mechanism of action makes it suitable for long-term use.

SS-31, also known as elamipretide or FORZINITY, is a synthetic mitochondrial cardiolipin-binding tetrapeptide. It localizes to the inner mitochondrial membrane and is studied for cytoprotective and antioxidant effects in mitochondrial and cardiovascular disease contexts.

Tabimorelin is an orally active growth hormone secretagogue that stimulates GH release through the ghrelin receptor (GHS-R1a). It has been studied in healthy volunteers and adults with growth hormone deficiency, where it showed short-term GH stimulation, but longer-term clinical benefits remain unproven.

TB-500 is a synthetic version of the naturally occurring peptide Thymosin Beta-4, which plays a crucial role in cellular regeneration and protection. It's primarily known for its ability to promote healing, reduce inflammation, and improve recovery from injuries. TB-500 works by regulating actin, a cell-building protein essential for cell structure and movement. This mechanism allows it to promote wound healing, increase flexibility, and enhance recovery from muscle, tendon, and ligament injuries. Athletes and bodybuilders often use TB-500 to accelerate recovery from injuries and training. It also demonstrates potential benefits for cardiovascular health by promoting the development of new blood vessels.

Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analog that has been FDA-approved for reducing excess visceral fat in HIV patients. It works by stimulating the pituitary gland to release growth hormone, which helps regulate body composition and metabolism. The peptide has shown effectiveness in reducing visceral fat while preserving muscle mass and improving overall body composition. Research suggests it may help prevent age-related changes in body composition and support healthy aging. Tesamorelin is particularly valuable for its ability to target visceral fat while maintaining muscle mass and supporting overall health. The peptide is often used in combination with exercise and proper nutrition for optimal results.

Tetracosactide is a synthetic peptide that mimics the action of ACTH (adrenocorticotropic hormone), playing a crucial role in regulating adrenal function and stress responses. It works by stimulating the adrenal glands to produce cortisol and other stress hormones. It is primarily used as a diagnostic aid in the assessment of suspected adrenocortical hypofunction, with any therapeutic use depending on the specific formulation and indication. The peptide is often discussed in the context of adrenal-support protocols, but repeated therapeutic dosing is formulation-specific and should be guided by medical supervision.

Thymalin is a thymus-extract peptide drug derived from calves and young cattle. It is used as an immunostimulant to help restore impaired immunological reactivity, including T- and B-lymphocyte balance, cellular immune responses, phagocytosis, and suppressed regeneration and hematopoiesis.

Thymogen is a synthetic dipeptide immunomodulator (alpha-glutamyl-tryptophan, L-Glu-L-Trp) that has been studied for support of immune system function and thymic activity. It is used in clinical and research settings for immune modulation, with labeled formulations available as an injectable product or nasal spray. The peptide has been explored for effects on T-cell function, inflammation, and recovery support, but evidence remains limited and indication-specific.

Thymosin Alpha-1 is a naturally occurring peptide that plays a crucial role in immune system function and T-cell maturation. It works by modulating various aspects of the immune response, including T-cell development, cytokine production, and immune cell activation. The peptide has shown effectiveness in enhancing immune function, improving resistance to infections, and supporting overall health. Research suggests it may help treat various immune-related conditions and support recovery from illness. Thymosin Alpha-1 is particularly valuable for its ability to enhance immune system function while maintaining proper immune balance. The peptide is often used in combination with other immune-supporting compounds for comprehensive benefits.

Thymosin Beta-4 is a naturally occurring peptide that plays a crucial role in tissue repair and regeneration. It works by promoting cell migration, angiogenesis, and tissue remodeling. The peptide has shown effectiveness in enhancing recovery, supporting wound healing, and reducing inflammation. Research suggests it may help prevent tissue damage and support overall health. Thymosin Beta-4 is particularly valuable for its ability to enhance tissue repair while maintaining proper healing processes. The peptide is often used in combination with other recovery-supporting compounds for comprehensive benefits.

Thymulin is a zinc-dependent thymic peptide involved in T-cell development and immune modulation. Most supporting evidence comes from laboratory and animal studies, and clinical use remains investigational. It is discussed in the context of thymus support, immune balance, and inflammatory signaling.

Tirzepatide (Mounjaro) represents a breakthrough in weight loss and diabetes management as the first dual GIP/GLP-1 receptor agonist. By simultaneously targeting both the GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors, it achieves superior efficacy compared to single-receptor agonists. Clinical trials have demonstrated average weight loss of 15-20% of body weight at the highest dose, with significant improvements in blood sugar control, blood pressure, and cholesterol levels. The medication works through multiple mechanisms: reducing appetite and food intake, slowing gastric emptying, improving insulin sensitivity, and promoting satiety. It has shown particular effectiveness in individuals with type 2 diabetes, where it not only helps with weight loss but also significantly improves glycemic control and cardiometabolic risk factors.

Triptorelin is a synthetic GnRH agonist that initially stimulates and then suppresses the hypothalamic-pituitary-gonadal axis. It binds GnRH receptors in the pituitary, causing a transient LH/FSH surge followed by receptor desensitization and reduced gonadotropin production. Clinically, this sustained suppression is used in hormone-suppression indications, and endogenous hormone production may recover after treatment stops.

Vasopressin (also known as antidiuretic hormone or ADH) is a naturally occurring peptide hormone that plays crucial roles in water balance, blood pressure regulation, and memory formation. It works by binding to specific receptors in the kidneys, blood vessels, and brain. In the kidneys, it promotes water retention by increasing water reabsorption. In the brain, it modulates memory formation and social behavior. Vasopressin has shown effectiveness in improving memory consolidation, enhancing focus, and regulating fluid balance. Research suggests it may help treat certain forms of memory impairment and support cognitive function. The peptide is particularly valuable for its ability to enhance memory while maintaining proper hydration and blood pressure levels.

Vialinin A is a naturally occurring p-terphenyl natural product isolated from Thelephora fungi. It is a small-molecule inhibitor of ubiquitin-specific peptidases, especially USP4 and USP5, and has been studied mainly for anti-inflammatory and antioxidant activity in preclinical models.

VIP (Vasoactive Intestinal Peptide) is a naturally occurring peptide that acts as a neurotransmitter and hormone throughout the body. It plays roles in immune function, inflammation regulation, and brain health. VIP works through multiple mechanisms, including modulating immune responses, regulating inflammation, improving blood flow, and supporting brain function. It has been studied in inflammatory conditions, autoimmune disorders, and certain neurological conditions. Research suggests it may have potential in multiple sclerosis, rheumatoid arthritis, and some neurodegenerative disorders, but its clinical use remains investigational.